Web Results

en.wikipedia.org/wiki/Palonosetron

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).

www.aloxi.com

Information for patients and caregivers about ALOXI® (palonosetron HCl).

www.rxlist.com/aloxi-drug.htm

Mar 14, 2016 ... ALOXI (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT3) receptor antagonist with a strong ...

www.drugs.com/cdi/palonosetron.html

Jul 5, 2017 ... Easy to read patient leaflet for palonosetron. Includes indications, proper use, special instructions, precautions, and possible side effects.

medlineplus.gov/druginfo/meds/a610002.html

Jan 15, 2015 ... Palonosetron Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.drugbank.ca/drugs/DB00377

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is the ...

reference.medscape.com/drug/aloxi-palonosetron-342053

Medscape - Antiemetic dosing for Aloxi (palonosetron), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ...

www.cancer.gov/about-cancer/treatment/drugs/palonosetronhydrochloride

May 6, 2010 ... This page contains brief information about palonosetron hydrochloride and a collection of links to more information about the use of this drug, ...

www.accessdata.fda.gov/drugsatfda_docs/label/2014/022233s005lbl.pdf

ALOXI. ALOXI (palonosetron HCl) Capsules Initial U.S. Approval: 2003 ... The potential for clinically significant drug interactions with palonosetron appears to be ...

www.accessdata.fda.gov/drugsatfda_docs/label/2006/021372s005lbl.pdf

administration. Each 5-ml vial of Aloxi injection contains 0.25 mg palonosetron base as hydrochloride, 207.5 mg mannitol, disodium edetate and citrate buffer in  ...